Acne vulgaris (AV) is a major skin disorder, 85% of adolescents between the ages of 15 and 17 have acne vulgaris; though, acne can affect anyone (1, 2). A chronic inflammatory pilosebaceous condition known as AV causes lesions on the skin in regions with a high concentration of big sebaceous glands, such as the face, chest, shoulders, and upper back (2). Age of the patient, lesion shape (comedonal, inflammatory, mixed, nodulocystic), distribution (facial, trunk, or both), and severity are used to categorize acne vulgaris (extent, presence or absence of scarring, post-inflammatory erythema, or hyperpigmentation) (2).

Although the majority of acne cases do not require a specific medical evaluation, a medical workup may occasionally be necessary (2–5). An estimated 9.4% of the global population is impacted by acne and the majority of them were being female (4–6). A more recent study in Saudi Arabia reported a prevalence of 78.5% of acne among university students (6). On the other hand, the American Academy of Dermatology revealed that acne impacted approximately 50 million Americans annually. Approximately 85% of acne sufferers were between the ages of 12 and 24 and making it the eighth most common disease on the planet (7). Additionally, patients who encounter side effects require continuous treatment, which increases the expense (3, 8–10). First-line treatments include topical therapy such as retinoid (such as tretinoin, and adapalene), benzoyl peroxide, azelaic acid, and/or combinations of topical medications (11). In a randomized trial including 207 participants, treatment with tretinoin 0.025% gel reduced the number of acne lesions at 12 weeks by 63% compared to baseline (11). Oral hormonal therapy such as combined oral conceptive drugs or spironolactone, oral antibiotics like doxycycline or minocycline, or Isotretinoin is most effective for more severe diseases (11). The studies on pharmacists’ knowledge and attitude toward acne management are more difficult to obtain since there are only a few studies on the topic throughout Saudi Arabia. Most studies have discussed the knowledge and practice of medical doctors regarding acne management. Previous studies in Saudi Arabia among healthcare providers’ reported low knowledge of acne management (1, 12, 13). Among those studies, a study by Khalid et al. (12) examined the knowledge, attitudes, and practices of doctors working in primary health care centers about acne vulgaris. It was a cross-sectional study carried out in 30 PHCs in Riyadh in 2000 and involved 144 physicians (13). Inappropriate behavior and a lack of understanding among the health care professionals were the outcomes that were associated with lower knowledge of acne. On the other hand, another cross-sectional by Al-Shobaili et al., in 2012 in the Qassim region conducted among physicians working at Primary Health Care facilities and reported that there was a lack of knowledge and practice of acne (1). Similarly, another study by Alotaibi et al., carried out to assess the knowledge and practice of primary healthcare physicians for the management of Acne Vulgaris in the Sudair area in Saudi Arabia, found that 49% of physicians had good knowledge, 44% had moderate knowledge and 7% had poor knowledge (12).

Community pharmacists are frontline healthcare workers and are regarded as experts in patient education and counseling (14–20). This includes gathering a patient’s medical and medication history, observing the quantity and kind of lesions, choosing the best therapeutic plan, counseling the patient, and, if necessary, referring the patient to a doctor. Patients must be informed about the treatment’s objectives, reasonable expectations, length of therapy, appropriate product use, and the significance of following the regimen to reap the greatest benefits (14–17). Community pharmacists are in a prime position to dispense the best course of action for people with mild-to-moderate illnesses and refer people with severe instances for additional evaluation (14–17). As far as we are aware, no such study or survey has been carried out in Saudi Arabia to explore the knowledge, practice, and attitude of CPs on acne management. This study was undertaken among pharmacists working at CPs in central Saudi Arabia to examine their knowledge, attitude, and practice for acne management because pharmacist knowledge is crucial to the proper treatment of AV and its psychological effects.

A total of 313 CPs were enrolled in the study and successfully returned the questionnaire. Most CPs were between 25 and 35 years of age. Most of them (34.8%) had less than 5 years of practice in a community pharmacy setting. The demographic information gathered is summarized in Table 1.

This study found that the mean score of knowledge on etiology, pathophysiology, and therapy for AV was 5.3 ± 1.5. However, the majority of participants had a moderate level of knowledge (80.8%), followed by mild–moderate (12.8%). The total knowledge levels were low 12.8% (n = 40), moderate 80.8% (n = 253), and high 6.4% (n = 20).

Table 2 shows the CP’s responses to questions on the physiological issues and causes of acne. The most of causes of acne were hormones (82.7%), followed by bacteria (81.5%), stress (62.9%), and cosmetics (35.4%). The majority of the CPs stated that topical antibiotics are most frequently used to treat acne in general (87.5%), followed by oral Antibiotics (78.3%), and topical retinoids (73.8%). On the other hand, 93% of the pharmacists agreed that topical antifungal drugs should not be used to treat acne (Table 2). A Fishers Exact test was run at a significance level of 0.05 to establish the relationship between the socio-demographic characteristics of the participants and knowledge levels. The results showed no difference, except the type of pharmacy where the CPs work (p = 0.043) was found as presented in Table 3.

The results of the simple linear multiple regression analysis revealed that, type of pharmacy where CPs were worked, years of practice and graduation country were not significant predictor of knowledge score (p = 0.05), except age of the CPs, which was significant predictor of the knowledge score (p = 0.006) of the acne as shown in the Table 4.

Assessing the CPs’ practice toward the management of acne is presented in Table 5. More than one-half of the participants believed that the course of treatment should go longer than 1 month. About 95% of the pharmacists preferred to refer patients with severe acne to a dermatologist, and about 71% of participants agreed to follow up with their patients. In terms of patient counseling for acne, 65% of pharmacists recommended diet changes, 60.1% advised patients to refrain from picking at pimples, 53% advised patients to avoid stress, and 65.8% of CPs instructed their patients to follow treatment regimens (Table 5).

Acne vulgaris significantly worsens a patient’s quality of life by impairing their psychosocial development and sense of self-worth. There are numerous over-the-counter and prescription acne therapies available, making it difficult for patients and healthcare professionals to select the most efficient course of treatment (29, 30). Due to its evident appearance, acne is very easy to diagnose, although there is a variety of over-the-counter (OTC) therapies available. Community pharmacies are the perfect place for acne patients to get guidance and treatment because of their accessibility and convenience. However, OTC therapy marketing and the social effects of acne, such as shame and embarrassment, may lead to patient requests or perceived preferences that may influence pharmacy staff recommendations while being inappropriate. Several studies in various contexts have found that acne sufferers have poor awareness of the origins of the problem, and there is even some evidence that local pharmacists have insufficient knowledge of the issue (3, 31). However, to guarantee that the illness is adequately controlled, patients must be educated on self-care and how to apply topical therapies. Many patients are suffering from minor to moderate illnesses that can be easily treated in pharmacies.

In this study, the majority of CPs (80.8%) showed moderate knowledge of acne management. Our results are better than previous studies published among CPs in other countries (2, 3) and primary healthcare providers in Saudi Arabia (1, 12). For instance, a study conducted among CPs in Palestine showed 69.3% had moderate knowledge, and 7.7% had high knowledge (2). Another study from Zambia reported health care providers involving CPs correctly answered questions about the treatment of acne. (3). In Saudi Arabia, a study conducted on primary care medical doctors revealed that 38.7% of doctors had a low level of knowledge, while only 11.3% had a high level of knowledge (1). A more recent study carried out in the center of, Saudi Arabia among primary healthcare physicians found that 49% of them had high while 44% had moderate, and 7% of the physicians were found to have poor knowledge of acne (12).

In the present study, hormone imbalances are the main cause of AV reported by the majority of CPs (82.7%), followed by bacteria (81.5%) and stress (62.9%). This is completely in line with the theory that hormonal variables are the first to cause acne to appear (32, 33). Numerous investigations have shown that P. acnes is the cause of acne (32, 34). However, it is also well known that the pathogenesis of acne vulgaris is multifaceted and may involve immunological disorders, genetic changes, stress, and cosmetics the full pathogenesis of acne is, however, not fully understood (35–37).

The goals of acne treatment are to reduce the severity and recurrences of skin lesions as well as to improve the look. The approach is determined by the degree of acne, the patient’s age, treatment preferences, and adherence to and reaction to the prior medication (30). The standard of care for mild to moderate acne is a topical medication (38). The cornerstones of topical acne therapy include retinoids and antimicrobials like benzoyl peroxide and antibiotics. Such therapies can stop the development of new lesions and are active where they are applied (39). In the present study, topical antibiotics and topical retinoids were dispensed by the majority of CPs. These recommendations are in line with the international guidelines which consider topical retinoids should be used as the initial treatment for mild-to-moderate inflammatory acne, either alone or in combination, and that it is also the best drug for maintenance therapy (40).

For practice, more than half of CPs agree that therapy should extend longer than a month. The international guidelines stated that therapy should initiate with first-line medications for 12 weeks (NICE). Even though therapy for acne can effectively alleviate its social, emotional, and psychological side effects, patient adherence to treatment is low (33). Healthcare providers such as pharmacists must acquire the ability to counsel both adults and adolescents to increase adherence. This study revealed that most CPs provided counseling on adherence to medication, diet modification, and stress. This study found that about 95% of CPs stated that they might refer acne patients to a doctor/dermatologist; this high referral rate in our study could be attributed to a lack of emphasis on ongoing care and poor counseling abilities. Only one community pharmacist can treat acne alone in his pharmacy, which reflects a lack of knowledge, counseling abilities, and effective communication. However, a study conducted in Palestine reported that about 25% of CPs can manage patients with acne in their community pharmacy setting (2).

Pharmacists are essential in the patient evaluation process. This includes gathering a patient’s medical and medication history, observing the quantity and kind of lesions, choosing the best therapeutic plan, counseling the patient, and, if necessary, referring the patient to a doctor. Patients must be informed about the treatment’s objectives, reasonable expectations, length of therapy, appropriate product use, and the significance of following the regimen to reap the greatest benefits (41). These protocols help distinguish between individuals who would benefit from treatment in the pharmacy and those who should be sent to other healthcare professionals. There are currently standardized methods available for pharmacists to treat acne (43). Therefore, CPs in Saudi Arabia should be able to communicate well and should advise acne patients on the many treatments available, how to utilize the treatment, how crucial it is to keep to the regimen, and any potential side effects like dryness and irritation.

Though, CPs in the present study had positive attitudes and behaviors about acne treatment. However, several research has shown that patients and providers’ attitudes toward acne and other skin diseases are negatively influenced by socio-psychological factors (22). Around 95% of the CPs inquire the patients about pregnancy, 91.7% inquire the woman patients for hormonal regularity, and 92.7% inquire the patients for their medical and drug history. Pharmacists identified several challenging factors, including poor pharmacist-patient communication due to space constraints in the pharmacy and gender embarrassment, a lack of experience in the management of acne, and difficulty accessing the most recent treatment recommendations for acne (2). All these factors should be addressed and avoided for better prescribing and patient counseling this highlights the need for national guidelines for the management of acne as well as increased continued educational programs for CPs through various seminars and presentations. Furthermore, organizations must provide social and financial support to enlarge their knowledge in the management of various minor ailments. This study has certain limitations. First, it has a small sample size, despite all efforts to include as many Cps as possible. Second, this study comprised CPs from a single region in Saudi Arabia, limiting the generalizability of the results. Despite these limitations, our study has several merits. To begin, this study considers the significance of acne suffers expertise in providing better treatment and QOL for acne sufferers. There is also a scarcity of such research in the field, notably among CPs in this concept in Saudi Arabia.

The current study demonstrated that CPs have a positive attitude and good practices for treating acne, although they still need to improve their knowledge. Only 6.8% of CPs have high knowledge, whereas the majority of CPs had a moderate level of knowledge about acne. In addition, very few CPs can treat acne in their pharmacy setting. As a result, it is advised to identify the elements that limit CPs’ ability to provide effective acne management. Furthermore, a communication gap between the patient and the CPs caused in poor adherence to tropical treatment. Therefore, is important to improved patient and pharmacist communication aids in comprehending the patient’s issue, resulting in a better treatment outcome. Future research aimed at developing guidelines to improve the communication of dose regimen instructions by community pharmacists to acne patients may aid in the proper management of acne by community pharmacists. There is a need to encourage pharmacists to engage in structured and concentrated acne management professional training programs.

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study.

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

The authors of this study extend their appreciation to Researchers Supporting Project (Project number RSP-2023/81), King Saud University, Saudi Arabia.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.